The business club reported on March 8th that the Chinese-Russian pharmaceutical trade reappeared in 2010: a total of 675 million U.S. dollars worth of imports and exports, an increase of 32% year-on-year, of which exports hit a record high, reaching 630 million U.S. dollars, an increase of 39% year-on-year.

The growth of Western medicine products has increased significantly. China exported 384 million US dollars of Western medicine products in 2010, an increase of 33% year-on-year. Among them, western medicine raw materials are still the main varieties exported to Russia, the proportion of which is over 50%, and the export amount is 331 million US dollars, an increase of 29% over the same period of last year. Export varieties mainly include amino acids, antibiotics and anti-infections. It is worth mentioning that the export volume of western medicine preparations reached US$20.43 million, an increase of 65% compared to the same period of last year. Russia has also become one of the major countries for exporting western medicines for the first time. As more preparations in China pass the registration of Russian drugs and their price advantage, it is expected that the export of western medicine preparations in 2011 will reach 30 million US dollars.

Exports of traditional Chinese medicine products are still not stable. Chinese medicine exports to Russia amounted to USD7.11 million, an increase of 50% year-on-year, but Chinese medicine has consistently accounted for the smallest share of exports of pharmaceutical products to Russia, only about 1%, and the export situation is not enough. Stability, frequent trade surges or sharp declines. For example, the export of proprietary Chinese medicines, Chinese herbal medicines and decoction pieces last year saw a reduction in the prices of Chinese herbal medicines at different levels, and the instability of the importer’s team was also a factor affecting exports.

The export of plant extracts increased greatly in 2010. The export volume was 3,339,500 US dollars, an increase of 284.64% year-on-year, becoming a new bright spot for the export of Chinese herbal medicine products in recent years. It is understood that because some companies' exports are not declared according to the code of plant extracts, the actual amount of plant extracts exported to Russia is far more than that.

The prospects for the export of medical devices are promising. Russia is a major exporter of medical devices in China. In recent years, the growth rate of exports to Russia has been accelerating. In 2010, it exported 238 million U.S. dollars, an increase of 48% year-on-year. The export value of hospital diagnosis and treatment equipment with high added value has risen sharply. The export value exceeded the USD 100 million mark for the first time, an increase of 59% year-on-year. With the further improvement of the Russian health care system and the continuous renewal of medical facilities, the demand for medical devices will continue to increase.

The pharmaceutical market capacity has further increased. Russia's current fiscal and economic conditions are good. Experts predict that the capacity of the Russian pharmaceutical market will reach 400 billion to 500 billion rubles in 2011, and per capita (taking into account population growth) will reach the European average level of drug consumption, according to The Russian Federation’s long-term social and economic development plan before 2020, before 2020, the Russian pharmaceutical market will reach 1.5 trillion rubles.

Related Reports Recommendations for Developing the Russian Market Russia, Kazakhstan, and Belarus have reached an agreement on customs unions, among which health products have become more convenient (except medicines) for customs clearance in the three countries, and they are permanently effective. This has allowed more Chinese medicine companies to enter the country. Russia and even the CIS countries provide a convenient market. My Chinese medicine company cannot always hold the idea of ​​re-registration of customers. It should seize the opportunity to register products first and obtain a permit to enter the Russian market so that preparations can be made as soon as possible.

Without violating Russian law, the marketing of Chinese medicine health products can be advertised and sold through direct sales. It is also possible to cooperate with local senior health clubs to promote products.

To open up the Russian market, companies need to dig their hearts to study the market and slowly overcome it. Many enterprises in China have opened up for 5 years and 10 years and have finally achieved results. Therefore, some companies say: "To treat the Russian market, we must not simply touch it. If we want to deal with it slowly, what we need is specificity and patience."

Looking at the Sino-Russian pharmaceutical trade in the past decade, before 2006, Sino-Russian pharmaceutical trade showed a continuous deficit. In the past five years, Russia’s pharmaceutical trade has reached double-digit export growth, and Russia’s potential as a new emerging pharmaceutical market has grown in recent years. Already highlighted. China-Russia pharmaceutical trade has entered the track of healthy development. The increase in the demand for the Russian pharmaceutical market and the importance that local people place on health care provide more opportunities for Chinese companies. As long as Chinese companies accelerate the pace of product registration and strengthen communication with Russian customers, they will certainly be able to make some gains.